High Ki-67 score is indicative of a greater benefit from adjuvant chemotherapy when added to endocrine therapy in Luminal B HER2 negative and node-positive breast cancer

This publication has 17 references indexed in Scilit:

• Ki67 Index, HER2 Status, and Prognosis of Patients With Luminal B Breast Cancer
  JNCI: Journal of the National Cancer Institute, 2009
• Ki-67 as prognostic marker in early breast cancer: a meta-analysis of published studies involving 12 155 patients
  British Journal of Cancer, 2007
• The molecular portraits of breast tumors are conserved across microarray platforms
  BMC Genomics, 2006
• Estrogen-Regulated Genes Predict Survival in Hormone Receptor–Positive Breast Cancers
  Journal of Clinical Oncology, 2006
• Breast Cancer Molecular Subtypes Respond Differently to Preoperative Chemotherapy
  Clinical Cancer Research, 2005
• Repeated observation of breast tumor subtypes in independent gene expression data sets
  Proceedings of the National Academy of Sciences, 2003
• Ki‐67 expression in breast carcinoma
  Cancer, 2003
• Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications
  Proceedings of the National Academy of Sciences, 2001
• Molecular portraits of human breast tumours
  Nature, 2000
• Distinctive gene expression patterns in human mammary epithelial cells and breast cancers
  Proceedings of the National Academy of Sciences, 1999